Meet us at MEDICA 2025! 📅 Nov. 17–20 | Hall 3 Booth D43 | Schedule a meeting

EU-REP

ISO 15223-1 Amendment: EC-REP Symbol Changes to EU-REP

MedNet EC-REP GmbH is pleased to announce an important update to the symbol for European Authorized Representatives. The International Organization for Standardization (ISO) has recently amended ISO 15223-1:2021, introducing a change from "EC-REP" to "EU-REP" for the European Authorized Representative symbol.

This modification aims to eliminate potential confusion with Ecuador's country code (EC) and enhance clarity in medical device labeling. The amendment, ISO 15223-1:2021/Amd 1:2025, specifies that the authorized representative in the European Union will now be identified by "EU-REP" instead of "EC-REP".

Key Points for Manufacturers:

  1. Gradual Transition: There is no immediate requirement to change your labels. We recommend implementing the new symbol when other label modifications become necessary
  2. Updated Symbol Usage: When updating your labels, please use our contact details with the new EU-REP symbol
  3. Notified Body Requirements: If a Notified Body is involved in your product's conformity assessment, they may have specific transition period requirements. We advise contacting them directly for guidance

This amendment reflects the ongoing efforts to streamline and clarify medical device regulations across the European Union. MedNet EC-REP GmbH remains committed to supporting our clients through this transition and ensuring compliance with the latest regulatory standards.

For any questions or concerns regarding this change, please don't hesitate to contact our team. We're here to assist you in navigating these updates and maintaining full compliance with EU regulations.

Latest news

Implications of the Update to the Borderline & Classification Manual under MDR and IVDR

Implications of the Update to the Borderline & Classification Manual under MDR and IVDR

On 12 September 2025, the European Commission published Version 4 of the Manual on Borderline and Classification under Regulations (EU) 2017/745 and 2017/746, developed by the Borderline and Classification Working Group (BCWG).

Regulatory Affairs Bulletin: Intended Purpose vs Intended Use under MDR & IVDR

Regulatory Affairs Bulletin: Intended Purpose vs Intended Use under MDR & IVDR

European regulations EU 2017/745 (MDR) and EU 2017/746 (IVDR) require precise definitions in technical documentation, and the distinction (or overlap) between intended purpose and intended use remains a topic of operational significance.

MedNet EC-REP GmbH at MEDICA 2025 – Visit Us in Hall 3, Booth D43

MedNet EC-REP GmbH at MEDICA 2025 – Visit Us in Hall 3, Booth D43

MedNet EC-REP GmbH is pleased to announce that we will once again be exhibiting at MEDICA 2025 in Düsseldorf, the world’s leading trade fair for the medical technology industry.

EU eIFU Regulation Update Draft: What Medical Device Professionals Need to Know

EU eIFU Regulation Update Draft: What Medical Device Professionals Need to Know

The European Commission has introduced a significant amendment to Implementing Regulation (EU) 2021/2226, impacting how medical device manufacturers provide instructions for use (IFU).

Understanding the Interplay: MDR, IVDR, and the AI Act – Key Insights from MDCG 2025-6

Understanding the Interplay: MDR, IVDR, and the AI Act – Key Insights from MDCG 2025-6

Recently, the MDCG, in conjunction with the Joint Artificial Intelligence Board (AIB), released the MDCG 2025-6 FAQ document, offering essential clarifications on the interplay between the MDR, the IVDR, and the Artificial Intelligence Act (AIA).

Navigating IVDR and MDR Performance Studies: Key Insights from MDCG 2025-5 Q&A

Navigating IVDR and MDR Performance Studies: Key Insights from MDCG 2025-5 Q&A

The European Medical Device Coordination Group (MDCG) has released its latest guidance, MDCG 2025-5, a comprehensive Questions & Answers document addressing performance studies for in vitro diagnostic medical devices (IVDs) under Regulation (EU) 2017/746 (IVDR).

MDCG 2019-11 Rev.1: Important Changes for Medical Device Software Developers

MDCG 2019-11 Rev.1: Important Changes for Medical Device Software Developers

In the dynamic world of medical device regulation, staying abreast of the latest guidance is paramount for manufacturers. The Medical Device Coordination Group (MDCG) has recently released a significant update to its MDCG 2019-11 guidance document, now designated as MDCG 2019-11 Rev.1.

MDCG 2025-4: Key Guidance for Medical Device Software on Online Platforms

MDCG 2025-4: Key Guidance for Medical Device Software on Online Platforms

The European Commission's Medical Device Coordination Group (MDCG) has released the MDCG 2025-4 guidance document, titled "Guidance on the safe making available of medical device software (MDSW) apps on online platforms."